Lundbeckfond Ventures

5AM Ventures and Lundbeckfond Ventures co-lead $16M Series A for scPharmaceuticals Inc

5AM Ventures and Lundbeckfond Ventures led the $16 million Series A round for scPharmaceuticals, a pharmaceutical firm that is establishing products for subcutaneous delivery, a statement about the funding said.

Read Full Article

Biotech firm Thesan Pharmaceuticals closes $49M in Series B round

Thesan Pharmaceuticals, a biotech firm that develops therapies for skin conditions, raised $49 million for its Series B round led by existing investor Novo Ventures and joined in by SV Life Sciences, Lundbeckfond Ventures and Novartis Venture Fund.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics